Treatment | ANOVA (P-value) | ||||||
---|---|---|---|---|---|---|---|
CON n = 12 |
CARN n = 12 |
PIV n = 12 |
CARN + PIV n = 12 | CARN | PIV | Interaction | |
Plasma, μmol/L | |||||||
free | 5.9 ± 0.9b | 15.8 ± 3.8a | 2.4 ± 1.0c | 7.8 ± 2.8b | 0.001 | 0.001 | 0.003 |
acetyl | 0.74 ± 0.14b | 1.87 ± 0.59a | 0.35 ± 0.12c | 0.94 ± 0.31b | 0.001 | 0.001 | 0.009 |
Liver, nmol/g wet tissue | |||||||
free | 61.2 ± 12.0bc | 119.3 ± 23.2a | 25.9 ± 8.9c | 74.5 ± 30.7b | 0.001 | 0.001 | n.s. |
acetyl | 1.04 ± 0.85bc | 3.42 ± 1.83a | 0.42 ± 0.55c | 1.83 ± 1.47b | 0.001 | 0.004 | n.s. |
LD muscle, nmol/g wet tissue | |||||||
free | 456 ± 132c | 1095 ± 225a | 213 ± 62d | 609 ± 173b | 0.001 | 0.001 | 0.011 |
acetyl | 296 ± 57b | 440 ± 83a | 167 ± 33c | 303 ± 78b | 0.001 | 0.001 | n.s. |
BF muscle, nmol/g wet tissue | |||||||
free | 429 ± 93c | 1034 ± 207a | 231 ± 64d | 547 ± 130b | 0.001 | 0.001 | 0.001 |
acetyl | 255 ± 44b | 459 ± 63a | 118 ± 34c | 262 ± 65b | 0.001 | 0.001 | n.s. |